An extra degree of precision will be added to radiation treatments for prostate cancer at Washington University School of Medicine in St. Louis following the installation of two new technologies in the Department of Radiation Oncology.
Duration : 0:2:33
“Patients’ choices in terms of what therapy to have for prostate cancer really are based on their individual situation and their acceptance of certain risks or benefits from that treatment.” Drs. Tewari (leader in prostate cancer research and surgery) and Schlegel (Department Chairman) of Cornell Urology discuss “treatment choices” in the context of patient profile and the acceptance of certain risks. They emphasize the importance of having all the right knowledge and being an informed prostate cancer patient when facing prostate cancer treatment decisions. Prostate cancer requires you to get through all the physician bias and make informed decisions in partnership with your prostate cancer doctor.
Duration : 0:1:22
http://www.medpagetoday.com
Anthony Zietman, M.D., Harvard and Massachusetts General Hospital
BOSTON, Sept. 26 — Proton radiation for early prostate cancer had an acceptable tolerability profile but produced little evidence of a “gee whiz” impact to support its cost, according to preliminary results from a phase I/II clinical trial.
Duration : 0:4:28
“A lot of the risk in terms of developing prostate cancer is genetic and not something we have full control over.” Dr. Schlegel (Department Chairman) of Cornell Urology discusses the role genetics play in Prostate Cancer.
Duration : 0:1:21
“Surgical removal of the prostate can either be done with an open incision, as has been traditionally been done, or with a robotic approach.” Dr. Tewari and Dr, Schlegel, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, present the two main type sof prostate cancer surgery, as well as explaining the advantages/disadvantages of each.
Duration : 0:1:16
Sen. Chris Dodd Talks About His Prostate Cancer Diagnosis
visit: http://firedoglake.com
Duration : 0:7:48
“It’s important to have a wide variety of different treatment approaches and different support groups for men who have prostate cancer.” Dr. Schlegel (Department Chairman) of Cornell Urology discusses various treatment options for men to consider when faced with prostate cancer. Including hormonal prostate cancer treatment options and surgical. He also discusses adjunctive therapies for prostate cancer patients.
Duration : 0:1:4
“Actually the first morning is very important, because by that time you know exactly how that patient is going to do down the road.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, shares both clinical and psychological dimensions of recovery and healing.
Duration : 0:1:17
An educational video describing treatment options for the prostate cancer patient at Chicago Prostate Cancer Center. World leader in minimally invasive treatments. Dr. Brian Moran, world renowned radiation oncologists in the field of prostate cancer and advanced biopsy techniques. Over 10,000 procedures performed since 1997. Brachytherapy provides cure rates equal to surgery and IMRT with lower risk of side effects. One time outpatient procedure, minimally invasive with return to normal activity within a day. Safe and effective. No risk of radiation exposure to family members.
Duration : 0:8:45
They have cancer on both sides of their family. Most families do. But, when Mark finds himself getting up in the middle night it starts a diagnosis that includes PSA (Prostate Specific Antigens) tests and a series of biopsies and lab tests that are at first, inconclusive.
Source: An Original HealthTheater.tv Production/In ociation with the Dept. of Urology, Weill-Cornell New York Presbyterian Hospital. Credits: Executive Producer:Sean Moloney
Duration : 0:2:2